MONCTON, NEW BRUNSWICK–(Marketwired – Oct. 19, 2015) – OrganiGram Holdings Inc. (TSX VENTURE:OGI)(OTCQX:OGRMF) (the “Company”) would like to provide its position pertaining to the medical marijuana industry’s use of pesticides during the growing process.
As highlighted by the recent lawsuits filed against a marijuana company operating in Colorado, the use of pesticides within the medical marijuana industry could potentially pose serious health concerns for patients.
OrganiGram has chosen to grow our products with Organic methods and thus produces the highest quality product available, without the use of harmful chemical pesticides. As such, the Company remains a proud holder of the ECOCERT Canada Certification, which validates the organic process under which OrganiGram produces medical marijuana.
“Producing a product with natural components, chemical free and organic processes is one of the core principles on which OrganiGram is based. I believe the recent US lawsuit shed further light on the benefits of the products that we provide to patients. We look forward to continuing to supply medicine that differentiates us from our peers and is the best solution for our clients,” said Roger Rogers, President & CFO.
About OrganiGram Holdings Inc.
Organigram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of medical marijuana in Canada. Organigram is focused on producing the highest quality, condition specific medical marijuana for patients in Canada. Organigram’s facility is located in Moncton, New Brunswick and the Company is regulated by the Marihuana for Medical Purposes Regulations.
Please visit www.organigram.ca for more information.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
OrganiGram Holdings Inc.
Director of Investor Relations